CHRISTINA CROLEY: Open Payments
NPI 1003480245 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,329 in 53 payments from 8 companies in 2025. Trend: 2023 $1,241 · 2024 $2,071 · 2025 $2,329
Food & beverage: $2,252Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $848 |
| Janssen Biotech, Inc. | 6 | $473 |
| Madrigal Pharmaceuticals | 11 | $354 |
| EVOKE PHARMA, INC. | 5 | $200 |
| Ardelyx, Inc. | 3 | $167 |
| Novo Nordisk Inc | 1 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $109 |
| Teva Pharmaceuticals USA, Inc. | 1 | $53 |
Products named: TREMFYA, SKYRIZI, REZDIFFRA, RINVOQ, GIMOTI, IBSRELA, MAVYRET, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
